Price T Rowe Associates Inc Veru Inc. Call Options Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VERU
# of Institutions
116Shares Held
58MCall Options Held
539KPut Options Held
367K-
Adage Capital Partners Gp, L.L.C. Boston, MA7.86MShares$5.74 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.65MShares$5.59 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY7.06MShares$5.16 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$4.46 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.46MShares$3.99 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $58.5M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....